These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 30590288)

  • 1. Identifying cognitive subgroups in bipolar disorder: A cluster analysis.
    Lima F; Rabelo-da-Ponte FD; Bücker J; Czepielewski L; Hasse-Sousa M; Telesca R; Solé B; Reinares M; Vieta E; Rosa AR
    J Affect Disord; 2019 Mar; 246():252-261. PubMed ID: 30590288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive subgroups among newly diagnosed patients with schizophrenia spectrum or bipolar disorders: A hierarchical cluster analysis.
    Miskowiak KW; Kjærstad HL; Lemvigh CK; Ambrosen KS; Thorvald MS; Kessing LV; Glenthoj BY; Ebdrup BH; Fagerlund B
    J Psychiatr Res; 2023 Jul; 163():278-287. PubMed ID: 37244066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementing cognitive screenings for outpatients with bipolar disorder following optimised treatment in a specialised mood disorder clinic.
    Miskowiak KW; Roikjer TK; Mariegaard J; Bech JL; Obel ZK; Vejstrup B; Hansen L; Kessing LV
    Eur Neuropsychopharmacol; 2024 Jul; 84():27-34. PubMed ID: 38643698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with the discrepancy between objective and subjective cognitive impairment in bipolar disorder.
    Bonnín CM; Sánchez-Moreno J; Lima F; Roca X; Segú X; Montejo L; Solé B; Hidalgo-Mazzei D; Martin-Parra S; Martínez-Arán A; Vieta E; Torrent C; Rosa AR
    J Affect Disord; 2024 Mar; 349():210-216. PubMed ID: 38190862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Data-driven cognitive phenotypes in subjects with bipolar disorder and their clinical markers of severity.
    Rabelo-da-Ponte FD; Lima FM; Martinez-Aran A; Kapczinski F; Vieta E; Rosa AR; Kunz M; Czepielewski LS
    Psychol Med; 2022 Jul; 52(9):1728-1735. PubMed ID: 33050962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predominant polarity in bipolar I and II disorders: A five-year follow-up study.
    Pallaskorpi S; Suominen K; Rosenström T; Mantere O; Arvilommi P; Valtonen H; Leppämäki S; García-Estela A; Grande I; Colom F; Vieta E; Isometsä E
    J Affect Disord; 2019 Mar; 246():806-813. PubMed ID: 30634112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staging, Neurocognition and Social Functioning in Bipolar Disorder.
    Tatay-Manteiga A; Correa-Ghisays P; Cauli O; Kapczinski FP; Tabarés-Seisdedos R; Balanzá-Martínez V
    Front Psychiatry; 2018; 9():709. PubMed ID: 30618879
    [No Abstract]   [Full Text] [Related]  

  • 8. Current understandings of the trajectory and emerging correlates of cognitive impairment in bipolar disorder: An overview of evidence.
    Van Rheenen TE; Lewandowski KE; Bauer IE; Kapczinski F; Miskowiak K; Burdick KE; Balanzá-Martínez V
    Bipolar Disord; 2020 Feb; 22(1):13-27. PubMed ID: 31408230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving Functioning, Quality of Life, and Well-being in Patients With Bipolar Disorder.
    Bonnín CDM; Reinares M; Martínez-Arán A; Jiménez E; Sánchez-Moreno J; Solé B; Montejo L; Vieta E
    Int J Neuropsychopharmacol; 2019 Aug; 22(8):467-477. PubMed ID: 31093646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional outcome assessment in bipolar disorder: A systematic literature review.
    Chen M; Fitzgerald HM; Madera JJ; Tohen M
    Bipolar Disord; 2019 May; 21(3):194-214. PubMed ID: 30887632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome predictors after functional remediation in patients with bipolar disorder.
    Solé B; Bonnín CM; Radua J; Montejo L; Hogg B; Jimenez E; Reinares M; Valls E; Varo C; Pacchiarotti I; Valentí M; Garriga M; Torres I; Martínez-Arán A; Vieta E; Torrent C
    Psychol Med; 2022 Jan; 52(2):314-322. PubMed ID: 32539879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring social and occupational functioning of people with bipolar disorder: A systematic review.
    Akers N; Lobban F; Hilton C; Panagaki K; Jones SH
    Clin Psychol Rev; 2019 Dec; 74():101782. PubMed ID: 31751878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifetime Psychotic Symptoms, Subthreshold Depression and Cognitive Impairment as Barriers to Functional Recovery in Patients with Bipolar Disorder.
    Bonnín CM; Jiménez E; Solé B; Torrent C; Radua J; Reinares M; Grande I; Ruíz V; Sánchez-Moreno J; Martínez-Arán A; Vieta E
    J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31323795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional remediation improves bipolar disorder functioning with no effects on brain-derived neurotrophic factor levels.
    Bonnin CDM; Valls E; Rosa AR; Reinares M; Jimenez E; Solé B; Montejo L; Meseguer A; Pacchiarotti I; Colom F; Martinez-Aran A; Tomioka Y; Vieta E; Torrent C
    Eur Neuropsychopharmacol; 2019 Jun; 29(6):701-710. PubMed ID: 31076186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functioning and neurocognition in very early and early-life onset bipolar disorders: the moderating role of bipolar disorder type.
    Sleurs D; Speranza M; Etain B; Aouizerate B; Aubin V; Bellivier F; Belzeaux R; Carminati M; Courtet P; Dubertret C; Fredembach B; Haffen E; Groppi F; Laurent P; Leboyer M; Llorca PM; Olié E; Polosan M; Schwan R; Weill D; ; Passerieux C; Roux P
    Eur Child Adolesc Psychiatry; 2024 May; ():. PubMed ID: 38702455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bibliometric and visual analysis of cognitive function in bipolar disorder from 2012 to 2022.
    Cui X; Xue T; Zhang Z; Yang H; Ren Y
    Ann Gen Psychiatry; 2024 Apr; 23(1):13. PubMed ID: 38637833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of cognitive reserve on bipolar disorder: a systematic review.
    Matsumoto K; Hamatani S
    Front Psychiatry; 2023; 14():1341991. PubMed ID: 38371715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global reward processing deficits predict negative symptoms transdiagnostically and transphasically in a severe mental illness-spectrum sample.
    Luther L; Jarvis SA; Spilka MJ; Strauss GP
    Eur Arch Psychiatry Clin Neurosci; 2023 Dec; ():. PubMed ID: 38051397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of spironolactone as adjunctive therapy to sodium valproate in bipolar-I disorder: A double-blind, randomized, placebo-controlled clinical trial.
    Zandifar A; Badrfam R; Gholamian F; Shafiee A
    Brain Behav; 2023 Dec; 13(12):e3313. PubMed ID: 37933420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity and Reliability of the Digital Functioning Assessment Short Test (D-FAST) in the Brazilian Sample.
    Serafim SD; Goularte JF; Caldieraro MA; Lima FM; Dalpiaz G; Rabelo-da-Ponte FD; Torrent C; Solé B; Vieta E; Rosa AR
    Clin Pract Epidemiol Ment Health; 2022; 18():e174501792210121. PubMed ID: 37274864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.